Last week, it was announced that Genentech, a founding company in the biotech industry, plans to build a $700 million, ...

Genentech, American-headquartered in San Francisco, plans 420 jobs for the Wake County community of Holly Springs just outside of Raleigh.

The U.S. Federal Drug Administration (FDA) has granted Incyclix Bio Fast Track designation for INX-315 to treat ...

Headlines across North Carolina Monday and Tuesday included 400 new jobs in Holly Springs; flooding risk in the mountains eases; Congressman Chuck Edwards accused for hitting someone with a clipboard ...

Governor Josh Stein announced Monday that Genentech, one of the world’s premiere biotechnology companies, will invest $700 ...

Genentech plans to invest $700 million in a new facility in Holly Springs, North Carolina, creating 420 jobs and joining the ...

North Carolina Gov. Josh Stein announced that Genentech, a biotechnology company, will build a new manufacturing plant in Wake County, creating 420 jobs.

Genentech, a Bay Area-based biotech firm and member of the Switzerland-based Roche Group, plans to develop a $700 million pharmaceutical manufacturing facility in Holly Springs, approximately 20 miles ...

The proposed $700 million, 700,000-square-foot space will support the companies’ future joint portfolio of next-generation obesity medicines.

The committee awarded a grant to Genentech, a Roche subsidiary, to open a 420-worker, drug-manufacturing plant in the ...

North Carolina's life sciences sector continues to attract major investments with the potential for thousands of jobs.

US biotech Genentech and its parent, Swiss pharma giant Roche (ROG: SIX), have announced plans to invest more than $700 ...